Cutting-edge therapies exist, but the market cannot deliver them cheaply. Britain must build NHS capacity so that cures become collective goods, not expensive productsJust a small fraction of our 20,000 genes can cause disease when disrupted – yet that sliver accounts for thousands of rare disord... Read more
Theguardiantheguardian - Dec 21
According to the MarketGenics report, the global genomics & CRISPR market is projected to expand from USD 27.4 billion in 2025 to ~USD 134 billion by 2035, registering a CAGR of 17.2%, the highest during the forecast period. The global Read more
Openpr.com - Nov 07
